Dynamics of the vascular wall state in the treatment of patients with hypertension combined with obesity and diabetes mellitus
Journal Title: Міжнародний ендокринологічний журнал - Year 2018, Vol 14, Issue 6
Abstract
Background. Obesity and diabetes mellitus (DM) are considered to be the most important risk factors for arterial hypertension. Endothelial dysfunction is one of the principal causes of hypertension progression. Different schemes of combined drug therapy lead to an improvement in the state of the endothelium. The purpose of the work was to study the dynamics of endothelial function parameters in hypertensive patients with obesity and DM when using combined therapy. Materials and methods. Fifty four patients were enrolled in the study. Anthropometric data, carotid endothelial and aortic function, endothelin, total nitrate-nitrite content were evaluated in all subjects. Results. There was a decrease in both systolic (by 7.36 and 6.36 %, p < 0.05, respectively) and diastolic blood pressure (by 9.2 and 8.29 %, p < 0.05, respectively, in groups 1 and 2). In case of non-fixed drug therapy, the index of aortic stiffness (IAS) decreased by 7.05 % (p > 0.1), the intima-media thickness (IMT) — by 5.48 % (p > 0.1), the level of endothelin-1 — by 31.27 % (p > 0.1), whereas total nitric oxide (NO) content increased by 8.35 % (p > 0.1), endothelium-dependent vasodilation (EDVD) — by 10.5 % (p > 0.1). With a fixed combination of antihypertensive drugs, more pronounced changes occurred: IAS decreased by 10.96 % (p < 0.05), IMT — by 8 %, endothelin-1 — by 31.52 % (p < 0.05), while total NO increased by 8.7 % (p < 0.05), and EDVD — by 11.8 % (p < 0.05). Conclusions. In hypertensive patients with obesity and DM, there is an increase in the arterial stiffness, intima-media thickness, an increase in the level of endothelin, and a decrease in EDVD and the level of total nitrates. Fixed combination stimulates EDVD, improves the mechanisms of autoregulation and elastic properties of muscular vessels, and is more significant in controlling blood pressure.
Authors and Affiliations
B. A. Shelest
Keywords
Related Articles
- EP ID EP412503
- DOI 10.22141/2224-0721.14.6.2018.146066
- Views 67
- Downloads 0
Use of Neurovitan in the Treatment of Endocrine Polyneuropathy
Neurovitan may be the drug of choice in the implementation of complex therapy of neurotropic vitamins in patients with endocrine pathology. Objectiv: to study the effectiveness of Neurovitan in the complex treatment of...
Mechanism of Experimental Diabetic Cardiomyopathy Development
In experiment on 48 rats Na,K-ATPase and acetylcholinesterase activity was investigated in order to study the intensity and subsequence of cardiomyocyte membrane injuries induced by diabetic cardiomyopathy. The results a...
The state of carbohydrate metabolism in patients with polycystic ovary syndrome
Background. Today, the role of carbohydrate metabolism disorders in the pathogenesis of polycystic ovary syndrome (PCOS) is actively studied, because their timely diagnosis and correction can improve the reproductive hea...
Role of Foxo1 gene expression in mechanism of antihypertrophic action of metformin in cardiomyocytes
Background. Diabetic cardiomyopathy is the leading cause of mortality in patients with type 2 diabetes mellitus. Hypertrophy of cardiomyocytes is one of the main pathomorphological signs of diabetic cardiomyopathy develo...
Features of Treatment of Patients with Diabetes Mellitus Type 2 with Heart Failure (Literature Review)
Diabetes mellitus and heart failure are often comorbid conditions. The studies found that patients taking metformin as monotherapy (odds ratio 0.65 (0.48–0.87)) or in conjunction with other drugs (0.72 (0.59–0.90)), mort...